Short Interest in Esperion Therapeutics, Inc. (NASDAQ:ESPR) Decreases By 6.6%
Esperion Therapeutics, Inc. (NASDAQ:ESPR – Get Free Report) saw a large decline in short interest during the month of November. As of November 15th, there was short interest totalling 31,250,000 shares, a decline of 6.6% from the October 31st total of 33,460,000 shares. Based on an average daily volume of 3,820,000 shares, the days-to-cover ratio […]
More Stories
Keefe, Bruyette & Woods Forecasts Strong Price Appreciation for First Busey (NASDAQ:BUSE) Stock
First Busey (NASDAQ:BUSE – Free Report) had its target price increased by Keefe, Bruyette & Woods from $32.00 to $34.00...
Chemung Financial (NASDAQ:CHMG) Price Target Raised to $60.00 at Keefe, Bruyette & Woods
Chemung Financial (NASDAQ:CHMG – Free Report) had its target price raised by Keefe, Bruyette & Woods from $54.00 to $60.00...
Mizuho Initiates Coverage on Cencora (NYSE:COR)
Mizuho assumed coverage on shares of Cencora (NYSE:COR – Free Report) in a research report report published on Wednesday morning....
Asset Entities Inc. Acquires 50% Ownership Interest in Adaptation Rights for “One Step Closer: From Xero to #1: Becoming Linkin Park” Literary Work
Asset Entities Inc. (NASDAQ:ASST) announced on December 2, 2024, that the company has entered into a Purchase Agreement with Jeff...
Archer-Daniels-Midland (NYSE:ADM) Price Target Lowered to $51.00 at BMO Capital Markets
Archer-Daniels-Midland (NYSE:ADM – Free Report) had its target price cut by BMO Capital Markets from $55.00 to $51.00 in a...
Companhia Paranaense de Energia – COPEL (NYSE:ELP) Sees Large Increase in Short Interest
Companhia Paranaense de Energia – COPEL (NYSE:ELP – Get Free Report) saw a large growth in short interest in November....